ELVN Enliven Therapeutics, Inc. - Common Stock
$41.43
Price · May 20, 2026
Fundamentals as of May 7, 2026
52W Range
$15–$49
79% of range
Analyst Rating
BUY
16 analysts
Price Target
$57
+38% upside
P/E (TTM)
-8.4
ROE
-21.9%
Net Profit Margin
—
ELVN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$41.43
Market Cap
$915M
P/E (TTM)
-8.4
EPS (TTM)
$-1.83
Revenue (TTM)
—
Div Yield
—
ROE
-21.9%
Debt/Equity
—
52W Range
$15 – $49
ELVN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-1.83
2021-12-31
→
2025-12-31
Free Cash Flow
$-70M
2020-12-31
→
2025-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ELVN
Peer Median
P/E (TTM)
-8.4
42.1
P/B
2.0
3.7
Price / FCF
-13.0
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ELVN
Peer Median
ROA
-25.9%
-13.2%
ROE
-21.9%
-21.9%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ELVN
Peer Median
Current Ratio
28.7
4.1
Quick Ratio
27.9
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ELVN
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ELVN
Peer Median
ELVN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
16 analysts
- Strong Buy 5 31.2%
- Buy 10 62.5%
- Hold 1 6.2%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
8 analysts · 2026-05-18
Median
$57.50
← Below all targets
$41.43
Low
$45.00
High
$80.00
Median target
$57.50
+38.8%
Mean target
$57.00
+37.6%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.02%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.38 | $-0.47 | 0.09% |
| Dec. 31, 2025 | $-0.48 | $-0.39 | -0.09% |
| Sept. 30, 2025 | $-0.32 | $-0.44 | 0.12% |
| June 30, 2025 | $-0.49 | $-0.54 | 0.05% |
| March 31, 2025 | $-0.57 | $-0.51 | -0.06% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ELVN | $915M | -8.4 | — | — | -21.9% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| GPCR | $14.78B | -86.9 | — | — | -12.3% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| DFTX | $1.32B | -6.5 | 212.0% | — | -71.0% | — |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $86M | $81M | $65M | $31M | $38M | $32M | $19M | |
| SG&A Expense | $34M | $24M | $19M | $8M | $13M | $10M | $5M | |
| Operating Expenses | $120M | $105M | $84M | $39M | $51M | $42M | $24M | |
| Operating Income | $-120M | $-105M | $-84M | $-39M | $-51M | $-42M | $-24M | |
| Other Non-op | $-49.0K | $-2.0K | $-22.0K | $0 | $-175.0K | $-145.0K | $75.0K | |
| Pretax Income | · | · | · | $2M | $-51M | · | · | |
| Income Tax | $0 | $232.0K | $0 | $0 | · | · | · | |
| Net Income | $-104M | $-89M | $-72M | $-38M | $-51M | $-41M | $-23M | |
| EPS (Basic) | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 | · | · | |
| EPS (Diluted) | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 | · | · | |
| Shares (Basic) | 56,664,226 | 47,072,532 | 35,546,215 | 3,124,274 | 21,661,450 | · | · | |
| Shares (Diluted) | 56,664,226 | 47,072,532 | 35,546,215 | 3,124,274 | 21,661,450 | · | · | |
| EBITDA | $-119M | $-104M | $-83M | $730.0K | $-51M | $-42M | · |
Balance Sheet 22
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $124M | $100M | $76M | $48M | $48M | $5M | |
| Short-term Investments | $364M | $189M | $153M | $0 | · | · | · | |
| Prepaid Expense | $12M | $5M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $475M | $318M | $266M | $78M | $93M | $90M | $31M | |
| PP&E (Net) | $34.0K | $458.0K | $742.0K | $890.0K | $250.0K | $349.0K | $442.0K | |
| PP&E (Gross) | $263.0K | $1M | $1M | $1M | $479.0K | $479.0K | $475.0K | |
| Accum. Depreciation | $229.0K | $919.0K | $671.0K | $374.0K | $229.0K | $130.0K | $33.0K | |
| Other Non-current Assets | $656.0K | $7M | $4M | $0 | $175.0K | $88.0K | $2M | |
| Total Assets | $476M | $326M | $272M | $83M | $94M | $91M | $33M | |
| Accounts Payable | $2M | $1M | $532.0K | $3M | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | $2M | $5M | $4M | $3M | |
| Current Liabilities | $17M | $16M | $26M | $10M | $7M | $6M | $4M | |
| Capital Leases | $0 | · | $0 | · | $406.0K | · | · | |
| Other Non-current Liabilities | · | $0 | $67.0K | $659.0K | · | · | · | |
| Total Liabilities | $17M | $16M | $26M | $10M | $8M | $6M | $4M | |
| Common Stock | $59.0K | $49.0K | $41.0K | $1.0K | $27.0K | $18.0K | $1.0K | |
| Paid-in Capital | $806M | $553M | $400M | $6M | $234M | $181M | $6M | |
| Retained Earnings | $-347M | $-243M | $-154M | $-83M | $-147M | $-96M | $-55M | |
| AOCI | $334.0K | $55.0K | $141.0K | $0 | $-16.0K | $4.0K | $32.0K | |
| Stockholders' Equity | $460M | $310M | $246M | $-77M | $-43M | $84M | $-49M | |
| Liabilities + Equity | $476M | $326M | $272M | $83M | $94M | $91M | $33M | |
| Shares Outstanding | 59,440,045 | 48,936,459 | 41,292,027 | 3,570,019 | 26,287,264 | 17,548,263 | 702,510 |
Cash Flow 11
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $300.0K | $300.0K | $300.0K | $200.0K | · | · | · | |
| Stock-based Comp | $34M | $20M | $13M | $3M | $4M | $2M | $899.0K | |
| Other Non-cash | $-926.0K | $-5M | $-3M | · | · | · | · | |
| Operating Cash Flow | $-70M | $-73M | $-61M | $-32M | $-47M | $-37M | $-22M | |
| CapEx | $158.0K | $44.0K | $149.0K | $612.0K | $12.0K | $18.0K | $140.0K | |
| Investing Cash Flow | $-174M | $-36M | $-148M | $-612.0K | $-2M | $-17M | $-24M | |
| Stock Issued | · | $0 | $161M | $0 | · | · | · | |
| Net Stock Activity | · | $0 | $161M | · | · | · | · | |
| Financing Cash Flow | $219M | $133M | $234M | $-2M | $49M | $97M | $44M | |
| Taxes Paid | $0 | $209.0K | · | · | · | · | · | |
| Free Cash Flow | $-70M | $-73M | $-61M | $-36M | $-47M | $-37M | · |
Profitability 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -25.9% | -29.8% | -40.3% | 1.6% | -55.7% | -66.6% | · | |
| ROE | -21.9% | -29.8% | -28.2% | 13.5% | -55.4% | -46.2% | · | |
| ROIC | · | · | · | 0.76% | · | · | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 28.7 | 20.0 | 10.3 | 49.0 | 12.9 | 14.5 | · | |
| Quick Ratio | 27.9 | 19.7 | 9.8 | 48.2 | 6.7 | 7.6 | · |
Valuation (TTM) 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-104M | $-89M | $-72M | $-38M | $-51M | $-41M | · | |
| Market Cap | $915M | $1.10B | $571M | $430M | $237M | $1.55B | · | |
| P/E | -8.4 | -11.9 | -6.9 | -1.4 | -3.8 | · | · | |
| P/B | 2.0 | 3.6 | 2.3 | 4.8 | 2.8 | 18.3 | · | |
| P / Tangible Book | 2.0 | 3.6 | 2.3 | · | · | 18.3 | · | |
| P / Cash Flow | -13.0 | -15.0 | -9.3 | -12.1 | -5.1 | -41.4 | · | |
| P / FCF | -13.0 | -15.0 | -9.3 | -12.0 | -5.1 | -41.4 | · | |
| Earnings Yield | -11.9% | -8.4% | -14.5% | -73.7% | -26.3% | · | · |
Income Statement 12
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $21M | $21M | $18M | $21M | $25M | $21M | $21M | $19M | $20M | $18M | $20M | $15M | $12M | $8M | $8M | $8M | |
| SG&A Expense | $7M | $13M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $2M | $3M | $1M | |
| Operating Expenses | $28M | $34M | $25M | $29M | $32M | $27M | $27M | $25M | $26M | $23M | $24M | $20M | $16M | $10M | $11M | $9M | |
| Operating Income | $-28M | $-34M | $-25M | $-29M | $-32M | $-27M | $-27M | $-25M | $-26M | $-23M | $-24M | $-20M | $-16M | $-10M | $-11M | $-9M | |
| Other Non-op | $0 | $0 | $0 | $-2.0K | $-47.0K | $0 | $0 | $-1.0K | $-1.0K | $-9.0K | $-13.0K | $0 | $0 | $-136.0K | $0 | $127.0K | |
| Income Tax | · | $0 | $0 | $0 | · | $0 | $0 | $232.0K | · | $0 | $0 | · | · | · | · | · | |
| Net Income | $-24M | $-30M | $-20M | $-25M | $-29M | $-23M | $-23M | $-20M | $-23M | $-19M | $-21M | $-17M | $-15M | $-10M | $-11M | $-9M | |
| EPS (Basic) | $-0.38 | $-0.45 | $-0.32 | $-0.49 | $-0.57 | $-0.46 | $-0.48 | $-0.41 | $-0.54 | $-0.29 | $-0.51 | $-0.41 | $-0.80 | $-2.91 | $-3.27 | $-2.86 | |
| EPS (Diluted) | $-0.38 | $-0.45 | $-0.32 | $-0.49 | $-0.57 | $-0.46 | $-0.48 | $-0.41 | $-0.54 | $-0.29 | $-0.51 | $-0.41 | $-0.80 | $-2.91 | $-3.27 | $-2.86 | |
| Shares (Basic) | 62,799,326 | -107,585,904 | 62,093,795 | 52,105,052 | 50,051,283 | -91,315,569 | 48,267,458 | 48,075,035 | 42,045,608 | -87,406,707 | 41,030,874 | 40,961,024 | 40,961,024 | -6,085,171 | 3,228,692 | 3,103,974 | |
| Shares (Diluted) | 62,799,326 | -107,585,904 | 62,093,795 | 52,105,052 | 50,051,283 | -91,315,569 | 48,267,458 | 48,075,035 | 42,045,608 | -87,406,707 | 41,030,874 | 40,961,024 | 40,961,024 | -6,085,171 | 3,228,692 | 3,103,974 | |
| EBITDA | $-28M | · | $-25M | $-29M | $-32M | · | $-27M | $-25M | $-26M | · | $-24M | $-20M | $51M | · | $-5M | $-12M |
Balance Sheet 22
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $132M | $99M | $102M | $119M | $102M | $124M | $101M | $97M | $149M | $100M | $74M | $126M | $292M | $76M | $49M | $30M | |
| Short-term Investments | $320M | $364M | $376M | $371M | $188M | $189M | $191M | $216M | $171M | $153M | $190M | $152M | · | $0 | · | · | |
| Prepaid Expense | $11M | $12M | $5M | $5M | $5M | $5M | $5M | $6M | $7M | $3M | $5M | $5M | $6M | $2M | $3M | $4M | |
| Current Assets | $463M | $475M | $483M | $496M | $294M | $318M | $297M | $318M | $337M | $266M | $269M | $283M | $298M | $78M | $59M | $64M | |
| PP&E (Net) | $20.0K | $34.0K | $399.0K | $462.0K | $404.0K | $458.0K | $549.0K | $630.0K | $683.0K | $742.0K | $806.0K | $867.0K | $853.0K | $890.0K | · | $105.0K | |
| PP&E (Gross) | · | $263.0K | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | |
| Accum. Depreciation | $243.0K | $229.0K | $1M | $1M | $993.0K | $919.0K | $908.0K | $828.0K | $750.0K | $671.0K | $593.0K | $515.0K | $441.0K | $374.0K | · | · | |
| Other Non-current Assets | $1M | $656.0K | $7M | $7M | $7M | $7M | $7M | $8M | $4M | $4M | $4M | $3M | $3M | $0 | · | $175.0K | |
| Total Assets | $465M | $476M | $491M | $504M | $303M | $326M | $305M | $327M | $343M | $272M | $274M | $289M | $303M | $83M | $59M | $65M | |
| Accounts Payable | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | $3M | $532.0K | $1M | $3M | $6M | $3M | $767.0K | $1M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | $2M | |
| Current Liabilities | $11M | $17M | $15M | $15M | $14M | $16M | $17M | $22M | $25M | $26M | $12M | $9M | $11M | $10M | $2M | $3M | |
| Capital Leases | $0 | $0 | $103.0K | $204.0K | $302.0K | · | $0 | $0 | $0 | · | $81.0K | $162.0K | $242.0K | · | · | · | |
| Other Non-current Liabilities | · | · | $103.0K | $204.0K | $302.0K | · | $0 | $6.0K | $34.0K | $67.0K | $214.0K | $360.0K | $508.0K | $659.0K | · | · | |
| Total Liabilities | $11M | $17M | $15M | $15M | $14M | $16M | $17M | $22M | $25M | $26M | $12M | $10M | $11M | $10M | $2M | $3M | |
| Common Stock | $61.0K | $59.0K | $59.0K | $59.0K | $49.0K | $49.0K | $47.0K | $47.0K | $47.0K | $41.0K | $41.0K | $41.0K | $41.0K | $1.0K | $27.0K | $27.0K | |
| Paid-in Capital | $824M | $806M | $793M | $786M | $560M | $553M | $508M | $502M | $495M | $400M | $397M | $393M | $389M | $6M | $235M | $235M | |
| Retained Earnings | $-371M | $-347M | $-317M | $-297M | $-272M | $-243M | $-220M | $-197M | $-177M | $-154M | $-135M | $-114M | $-98M | $-83M | $-178M | $-174M | |
| AOCI | $-382.0K | $334.0K | $221.0K | $-177.0K | $-16.0K | $55.0K | $242.0K | $-139.0K | $-53.0K | $141.0K | $-147.0K | $-111.0K | · | $0 | $-4.0K | $-35.0K | |
| Stockholders' Equity | $453M | $460M | $476M | $488M | $288M | $310M | $288M | $305M | $318M | $246M | $262M | $279M | $291M | $-77M | $57M | $61M | |
| Liabilities + Equity | $465M | $476M | $491M | $504M | $303M | $326M | $305M | $327M | $343M | $272M | $274M | $289M | $303M | $83M | $59M | $65M | |
| Shares Outstanding | 60,889,655 | 59,440,045 | 59,261,286 | 59,226,171 | 49,038,730 | 48,936,459 | 47,254,280 | 47,173,466 | 46,782,639 | 41,292,027 | 41,204,973 | 41,151,111 | 41,106,277 | 3,570,019 | 26,287,264 | 26,287,264 |
Cash Flow 11
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $14.0K | $83.0K | $62.0K | $81.0K | $74.0K | $62.0K | $80.0K | $79.0K | $79.0K | $80.0K | $79.0K | $74.0K | $67.0K | $-39M | $60.0K | $52.0K | |
| Stock-based Comp | $7M | $12M | $7M | $8M | $7M | $5M | $5M | $5M | $5M | $3M | $3M | $4M | $2M | $735.0K | $1M | $299.0K | |
| Other Non-cash | $-3M | · | · | · | $-2M | · | · | · | $-5M | · | · | · | $-75M | · | · | · | |
| Operating Cash Flow | $-19M | $-16M | $-13M | $-17M | $-24M | $-17M | $-12M | $-20M | $-23M | $-12M | $-16M | $-12M | $-21M | $-8M | $6M | $-325.0K | |
| CapEx | $0 | $0 | $-1.0K | $139.0K | $20.0K | $0 | $22.0K | $2.0K | $20.0K | $14.0K | $16.0K | $88.0K | $31.0K | $101.0K | $169.0K | $362.0K | |
| Investing Cash Flow | $43M | $12M | $-4M | $-184M | $1M | $727.0K | $15M | $-34M | $-18M | $39M | $-36M | $-152M | $-31.0K | $-101.0K | $-12M | $-6M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $-2M | $163M | $0 | $0 | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $0 | · | · | · | $163M | · | · | · | |
| Financing Cash Flow | $10M | $623.0K | $-368.0K | $218M | $234.0K | $40M | $1M | $2M | $90M | $90.0K | $-425.0K | $-3M | $237M | $-2M | $164.0K | $5.0K | |
| Taxes Paid | · | $0 | · | · | · | $-23.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-19M | · | · | · | $-24M | · | · | · | $-23M | · | · | · | $-21M | · | · | · |
Profitability 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -6.2% | · | -5.1% | -6.1% | -8.8% | · | -8.0% | -6.5% | -7.0% | · | -12.5% | -9.5% | -7.7% | · | -5.5% | -16.7% | |
| ROE | -6.4% | · | -5.3% | -6.4% | -9.4% | · | -8.4% | -6.8% | -7.5% | · | -13.0% | -9.8% | -8.1% | · | -5.9% | -18.1% |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 40.3 | · | 32.9 | 32.6 | 21.1 | · | 17.4 | 14.4 | 13.5 | · | 22.2 | 31.0 | 27.2 | · | 32.5 | 19.5 | |
| Quick Ratio | 39.4 | · | 32.6 | 32.2 | 20.7 | · | 17.1 | 14.1 | 12.8 | · | 21.8 | 30.4 | 26.7 | · | 27.2 | 9.2 |
Valuation (TTM) 8
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-98M | · | $-97M | $-97M | $-94M | · | $-87M | $-80M | $-75M | · | $-63M | $-51M | $-43M | · | $-42M | $-44M | |
| Market Cap | $2.39B | · | $1.21B | $1.19B | $965M | · | $1.21B | $1.10B | $823M | · | $563M | $840M | $900M | · | $240M | $128M | |
| P/E | -22.3 | · | -11.0 | -10.3 | -9.8 | · | -13.2 | -12.5 | -7.8 | · | -2.7 | -2.8 | -2.2 | · | -0.9 | -0.7 | |
| P/B | 5.3 | · | 2.5 | 2.4 | 3.3 | · | 4.2 | 3.6 | 2.6 | · | 2.2 | 3.0 | 3.1 | · | 4.2 | 2.1 | |
| P / Tangible Book | 5.3 | · | 2.5 | 2.4 | 3.3 | · | 4.2 | 3.6 | 2.6 | · | 2.2 | 3.0 | 3.1 | · | 4.2 | 2.1 | |
| P / Cash Flow | -123.7 | · | · | · | -40.0 | · | · | · | -35.2 | · | · | · | -43.2 | · | · | · | |
| P / FCF | -123.7 | · | · | · | -40.0 | · | · | · | -35.2 | · | · | · | -43.1 | · | · | · | |
| Earnings Yield | -4.5% | · | -9.1% | -9.7% | -10.2% | · | -7.6% | -8.0% | -12.8% | · | -36.5% | -36.0% | -45.4% | · | -108.3% | -150.6% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Income | $-104M | $-89M | $-72M | $-38M | $-51M |
| Diluted EPS | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 28.7 | 20.0 | 10.3 | 49.0 | 12.9 |
| Quick Ratio | 27.9 | 19.7 | 9.8 | 48.2 | 6.7 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-70M | $-73M | $-61M | $-36M | $-47M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.